# Effect of Oral Zinc Sulfate on Jaundice in Neonates Admitted to Neonatal Intensive Care Unit

> **NCT05161611** · NA · COMPLETED · sponsor: **Makassed General Hospital** · enrollment: 60 (actual)

## Conditions studied

- Serum Bilirubin

## Interventions

- **DRUG:** Zinc sulfate
- **OTHER:** Placebo
- **OTHER:** Phototherapy

## Key facts

- **NCT ID:** NCT05161611
- **Lead sponsor:** Makassed General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-17
- **Primary completion:** 2022-08-28
- **Final completion:** 2022-08-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05161611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05161611, "Effect of Oral Zinc Sulfate on Jaundice in Neonates Admitted to Neonatal Intensive Care Unit". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05161611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*